Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterile India is an Indian pharmaceutical manufacturer focused on sterile active pharmaceutical ingredients (APIs) and related development and regulatory support services. The company operates WHO-GMP-certified manufacturing capabilities for sterile dry-powder antibiotic and related injectable API products, including penicillins, cephalosporins, carbapenems, proton pump inhibitors, and other anti-infective and gastrointestinal molecules. Publicly available sources describe the business as supplying domestic and international markets from the New Delhi/Kundli-Sonipat area. Rather than a clinical-stage biotech developer, Sterile India appears to be a commercial manufacturing company serving pharma customers with sterile API production and dossier support. Its profile is best understood as a private, active sterile API manufacturer in the broader healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterile India.